Aarti Pharmalabs Limited reported a minor chemical leak incident at its Unit-VI facility in Tarapur on March 22, disclosing the event under Regulation 30 of SEBI (LODR) Regulations, 2015. The pharmaceutical company took immediate precautionary measures to ensure employee safety and contain the situation.

Incident Details and Chemical Involved

The incident occurred during the loading of dimethyl sulphate, a low-cost industrial chemical, into a tanker at the company's Unit-VI facility located at Plot No. D-18, MIDC, Tarapur, Tal. & Dist.- Palghar. The minor leakage was cleared immediately following standard safety protocols.

Safety Response and Medical Care

Following the chemical leak, the company promptly sent 22 workers to a local hospital for precautionary observation. More than half of the affected employees have already been discharged, demonstrating the minor nature of the incident and effective medical response.

Regulatory Compliance and Investigation

Aarti Pharmalabs informed the local police station about the incident, and a FIR has been registered as per standard procedures. The investigation process is currently ongoing, with the company committing to full cooperation with investigation agencies.

Operational Recovery

Normal plant operations were safely restored within 24 hours of the incident, indicating effective containment and minimal operational disruption. The quick resumption of activities demonstrates the company's operational resilience and emergency response capabilities. No loss of life or damage to property was reported, confirming the effectiveness of immediate safety measures implemented at the site.

Aarti pharma labs Limited has provided clarification to BSE regarding a delay in regulatory disclosure under SEBI regulations. The company submitted the explanation on February 13, 2026, addressing concerns about missing the mandatory 24-hour disclosure timeline.

Disclosure Delay Details

The pharmaceutical company's clarification pertains to a Corporate Announcement that was submitted on February 6, 2026, at 04:21:06 PM under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The regulation mandates that material events be disclosed to stock exchanges within 24 hours of occurrence.

Reason for Delay

According to the company's explanation, the delay occurred due to operational circumstances beyond immediate control. The email communication containing the relevant query was received by the concerned official who was on leave from February 3 to February 5, 2026. This absence resulted in the matter not being addressed within the stipulated regulatory timeline.

The company emphasized that the delay was inadvertent and occurred only because the responsible official was unavailable during the critical period when the disclosure requirement arose.

Company Response

Aarti Pharmalabs Limited has formally requested BSE to take the clarification on record, acknowledging the circumstances that led to the delayed disclosure. The clarification letter was signed by Jeevan Bhargav Mondkar, Company Secretary and Legal Head, who holds ICSI membership number A22565.

The company's proactive approach in providing detailed explanation demonstrates its commitment to regulatory compliance and transparency with stock exchange authorities, despite the inadvertent delay in meeting the disclosure timeline.